🔗 Share this article

Chancellor Reeves has announced she is planning "specific steps to address household expense issues" in the upcoming Budget.

In comments to the BBC, she stated that lowering inflation is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the highest among the G7 developed nations this calendar year and next.

Possible Energy Bill Measures

Sources suggest the administration could take action to lower energy bills, for instance by slashing the current 5% rate of value-added tax applied on energy supplies.

A further option is to reduce some of the policy costs presently added to bills.

Budgetary Constraints and Analyst Expectations

The administration will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for such actions.

The consensus from most economists is that the Chancellor will have to introduce higher taxes or budget cuts in order to meet her self-imposed borrowing rules.

Previously on Thursday, calculations suggested there was a £22bn shortfall for the chancellor to address, which is at the more modest range of expectations.

"It is a joint job between the Bank of England and the government to bear down further on some of the causes of inflation," the Chancellor told the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on likely tax increases, the Treasury chief said the most recent data from the OBR had not altered her commitment to campaign commitments not to raise tax levels on earnings tax, sales tax or National Insurance.

She attributed an "uncertain world" with rising international and commercial issues for the fiscal revenue measures, probably to be directed on those "most able to pay."

Global Economic Disputes

Addressing concerns about the United Kingdom's commercial links with the Asian nation she said: "Our security interests always are paramount."

Last week's statement by Chinese authorities to tighten trade restrictions on rare earths and other materials that are key for advanced tech manufacturing led US President Donald Trump to suggest an additional 100% import tax on imports from the Asian country, raising the possibility of an all-out commercial conflict between the two global powers.

The US Treasury Secretary labeled China's decision "economic coercion" and "a global supply chain power grab."

Questioned on considering the American proposal to participate in its battle with China, Reeves said she was "deeply worried" by Chinese actions and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "bad for the global economy and generates further headwinds."

"I believe there are areas where we must confront Chinese policies, but there are also significant chances to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to get that balance correct."

The chancellor also confirmed she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."

Health Service Drug Pricing and Investment

The Chancellor also acknowledged that the cost the National Health Service pays for medicines could increase as a consequence of current discussions with the US government and its drugs companies, in exchange for reduced taxes and investment.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either halting or abandoning operations in the United Kingdom, with several attributing the low prices they are getting.

Recently, the government science advisor said the cost the health service pays for drugs would must increase to stop firms and drug research funding departing from the United Kingdom.

Reeves told the BBC: "We have seen due to the cost structure, that clinical trials, recent pharmaceuticals have not been available in the UK in the extent that they are in other European countries."

"Our aim is to ensure that individuals getting care from the National Health Service are can receive the finest essential medicines in the world. And so we are examining this situation, and... looking to attract more funding into the UK."